Oral and Transdermal Hormonal Contraception in Women After Kidney Transplantation

Transplantation Proceedings

Volumn 39, Issue 9, 2007, Pages 2759-2762

  Pietrzak, B ^a   Bobrowska, K ^a   Jabiry Zieniewicz, Z ^a   Kaminski, P ^a   Wielgos, M ^a   Pazik, J ^a   Durlik, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; GESTAGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HORMONAL CONTRACEPTION; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; LOW DRUG DOSE; MENSTRUATION DISORDER; ORAL CONTRACEPTION; OVARY CYST; PRIORITY JOURNAL; THROMBOPHLEBITIS; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BILIRUBIN; CONTRACEPTIVE AGENTS, FEMALE; CREATININE; DELAYED-ACTION PREPARATIONS; ETHINYL ESTRADIOL; FEMALE; FERTILITY; HEMATOCRIT; HUMANS; KIDNEY TRANSPLANTATION; NORGESTREL; OXIMES;

EID: 36049035644     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.09.014     Document Type: Article

References (9)

1. Pietrzak B., Wielgos M., Kamiński P., et al. Menstrual cycle and sex hormone profile in kidney-transplanted women. Neur Endocrin Lett 27 (2006) 198
2. Kramer H.J.M., Tolkoff-Rubin N.E., Williams W.W., et al. Reproductive and contraceptive characteristics of premenopausal kidney transplant recipients. Prog Transplant 13 (2003) 193
3. Lessan-Pezeshki M., Ghazizadeh S., Khatami M.R., et al. Fertility and contraceptive issues after kidney transplantation in women. Tranplant Proc 36 (2004) 1405
4. Neyhart C.D. Contraception in ESRD and immunosuppression for the pregnant transplant patient. ANNA J 25 (1998) 345
5. Drife J. Oral contraception and the risk of tromboembolism. What does it mean to clinicians and their patients?. Drug Safety 25 (2002) 893
6. Sibai B.M., Odlind V., Meador M.L., et al. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Sterill 77 Suppl 2 (2002) 19
7. D'Souza R.E., and Guillebaud J. Risk and benefits of oral contraceptive pills. Best Pract Res Clin Obst Gynecol 16 (2002) 133
8. Pechere-Bertschi A., Maillard M., Stalder H., et al. Renal hemodynamic and tubular responses to salt in women using oral contraceptives. Kidney Int 64 (2003) 1374
9. Archer D.F., Bigrigg A., Smallwood G.H., et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril 77 Suppl 2 (2002) 27